A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness. Researchers found that certain statins can latch onto a key muscle protein and ...

Patients with rheumatoid arthritis increased their leg muscle volume when treated with an anti-rheumatic drug, offering new hope for improved muscle health. Publishing in the prestigious journal, The ...

Cancer cachexia is a multifactorial syndrome marked by a severe loss of body weight due primarily to the wasting of skeletal muscle and adipose tissue. This syndrome is often accompanied by systemic ...

Researchers have illustrated how inflammatory and systemic factors contribute to myopenia, sarcopenia, and cachexia in rheumatoid arthritis, driving musculoskeletal aging and increased morbidity.

All muscular dystrophies cause muscle weakness, but life expectancy can vary dramatically between types of muscular dystrophy.

With the global population ageing rapidly, sarcopenia, a condition that affects millions of older adults and severely diminishes their quality of life, is emerging as an urgent public health issue.

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could transform treatment for one of cancer's most devastating complications.

Loss of muscle mass (muscle atrophy) can be a result of aging or lifestyle habits, like being inactive or eating a poor diet. Muscle loss can also point to hormone abnormalities or underlying health ...